Rosen Law Firm, a global investor rights law firm, announces it is
investigating potential securities claims on behalf of purchasers of the
securities of INC Research Holdings, Inc. (NASDAQ:INCR) resulting from
allegations that INC Research may have issued materially misleading
business information to the investing public.
On August 1, 2017, INC Research and inVentiv Health, Inc. (“inVentiv
Health”) announced the completion of a merger between the two companies.
On November 9, 2017, INC Research reported its first financial results
after combining with inVentiv Health. The Company’s combined results
were negatively impacted by merger-related expenses, an impairment
charge and increased amortization expenses. On this news, shares of INC
Research fell $16.35 per share or over 28% from its previous closing
price to close at $41.15 per share on November 9, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses
suffered by INC Research investors. If you purchased shares of INC
Research, please visit the firm’s website at http://www.rosenlegal.com/cases-1236.html
for more information. You may also contact Phillip Kim or Kevin Chan of
Rosen Law Firm toll free at 866-767-3653 or via email at [email protected]
or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm
or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation
by Institutional Shareholder Services for the number of securities class
action settlements annually obtained for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171110005726/en/